Bota Madalina, Popa Gheorghe, Blag Cristina, Tataru Alexandru
Department of Pediatrics II, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Department of Dermatology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Clujul Med. 2015;88(1):23-7. doi: 10.15386/cjmed-381. Epub 2015 Jan 28.
Infantile hemangiomas as frequent infancy tumors have been a controversial issue of medical scientists worldwide. Their clinical aspects are various and their physiopathology is yet to be fully understood. Numerous publications outline the characteristics, causes, evolution possibilities and therapeutic approaches. Deciding whether to treat or not is the main question of this kind of pathology. Hemangiomas that have complications or can cause irreversible damage need therapy. This is a brief review of up-to-date information regarding the presentation of infantile hemangiomas and target-therapies.
婴儿血管瘤作为常见的婴儿期肿瘤,一直是全球医学科学家们争论的焦点。它们的临床症状多种多样,其生理病理学仍有待充分了解。众多出版物概述了其特征、病因、发展可能性和治疗方法。决定是否进行治疗是这类病理学的主要问题。有并发症或会导致不可逆损害的血管瘤需要治疗。这是一篇关于婴儿血管瘤表现及靶向治疗的最新信息的简要综述。